Group A streptococcus necrotising fasciitis from a levonorgestrel-containing intrauterine system ('Mirena' coil)

被引：1
|
作者：
Saleh, S. [1 ]
Ahmad, G. [2 ]
Majumdar, A. [3 ]
机构：
[1] Blackpool Victoria Hosp, Dept Obstet & Gynaecol, Blackpool FY3 8NR, Lancs, England
[2] Burnley Gen Hosp, Burnley, Lancs, England
[3] Royal Blackburn Hosp, Blackburn, Lancs, England
来源：
JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2011年 / 31卷 / 02期
关键词：
SOFT-TISSUE INFECTIONS; MORTALITY;
D O I：
10.3109/01443615.2010.529962
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：192 / 194
页数：4
相关论文
共 50 条
  • [21] Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route
    Hofmann, Birte Maria
    Apter, Dan
    Bitzer, Johannes
    Reinecke, Isabel
    Serrani, Marco
    Hochel, Joachim
    Merz, Martin
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2020, 25 (06): : 417 - 426
  • [22] Mirena® (Levonorgestrel intrauterine system): A successful novel drug delivery option in contraception
    Rose, Susan
    Chaudhari, Angela
    Peterson, C. Matthew
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (10) : 808 - 812
  • [23] Bilateral periorbital necrotising fasciitis associated with invasive group: a Streptococcus infection
    McCabe, Grace Anne
    Hardy, Thomas
    Campbell, Thomas Gordon
    [J]. BMJ CASE REPORTS, 2020, 13 (12)
  • [24] Comparison of Human Papillomavirus Infection and Cervical Cytology in Women Using Copper-Containing and Levonorgestrel-Containing Intrauterine Devices
    Lekovich, Jovana P.
    Amrane, Selma
    Pangasa, Misha
    Pereira, Nigel
    Frey, Melissa K.
    Varrey, Aneesha
    Holcomb, Kevin
    [J]. OBSTETRICS AND GYNECOLOGY, 2015, 125 (05): : 1101 - 1105
  • [25] The need to distinguish between group A streptococcus and polymicrobial causes in necrotising fasciitis
    Gibney, Daniel R.
    Cheesbrough, John
    [J]. BRITISH MEDICAL JOURNAL, 2012, 345
  • [26] Levonorgestrel hormone releasing intrauterine system (Mirena®) as a contraceptive in egg donors: case report
    C. Kailasam
    V. Akande
    U. D. Gordon
    [J]. Journal of Assisted Reproduction and Genetics, 2005, 22 : 137 - 140
  • [27] COMPARISON OF LNG20, A NEW LEVONORGESTREL INTRAUTERINE SYSTEM, AND MIRENA FOR TREATMENT FOR MENORRHAGIA
    Gordenne, V
    Witzen, F.
    Foidart, J-M
    Matmon, T.
    Creinin, M. D.
    Fmnkenne, F.
    [J]. CONTRACEPTION, 2010, 82 (02) : 213 - 213
  • [28] Levonorgestrel hormone releasing intrauterine system (Mirena®) as a contraceptive in egg donors:: case report
    Kailasam, C
    Akande, V
    Gordon, UD
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2005, 22 (03) : 137 - 140
  • [29] Acute urticaria as a side effect of the Mirena (levonorgestrel-releasing intrauterine system): A case report
    Chen X.
    Wu X.
    Zhu H.
    [J]. BMC Research Notes, 7 (1)
  • [30] The levonorgestrel intrauterine system (Mirena®) for treatment of idiopathic menorrhagia.: Assessment of quality of life and satisfaction
    Lete, I.
    Obispo, C.
    Izaguirre, F.
    Orte, T.
    Rivero, B.
    Cornellana, M. J.
    Bermejo, I.
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2008, 13 (03): : 231 - 237
12345